Literature DB >> 14659749

A human synthetic combinatorial library of arrayable single-chain antibodies based on shuffling in vivo formed CDRs into general framework regions.

Ronit Azriel-Rosenfeld1, Moran Valensi, Itai Benhar.   

Abstract

We describe a novel approach for high-throughput screening of recombinant antibodies, based on their immobilization on solid cellulose-based supports. We constructed a large human synthetic single-chain Fv antibody library where in vivo formed complementarity determining regions were shuffled combinatorially onto germline-derived human variable-region frameworks. The arraying of library-derived scFvs was facilitated by our unique display/expression system, where scFvs are expressed as fusion proteins with a cellulose-binding domain (CBD). Escherichia coli cells expressing library-derived scFv-CBDs are grown on a porous master filter on top of a second cellulose-based filter that captures the antibodies secreted by the bacteria. The cellulose filter is probed with labeled antigen allowing the identification of specific binders and the recovery of the original bacterial clones from the master filter. These filters may be simultaneously probed with a number of antigens allowing the isolation of a number of binding specificities and the validation of specificity of binders. We screened the library against a number of cancer-related peptides, proteins, and peptide-protein complexes and yielded antibody fragments exhibiting dissociation constants in the low nanomolar range. We expect our new antibody phage library to become a valuable source of antibodies to many different targets, and to play a vital role in facilitating high-throughput target discovery and validation in the area of functional cancer genomics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14659749     DOI: 10.1016/j.jmb.2003.10.053

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

Review 1.  Site-selective orientated immobilization of antibodies and conjugates for immunodiagnostics development.

Authors:  Min Shen; Chandra K Dixit; James Rusling
Journal:  Methods       Date:  2016-11-19       Impact factor: 3.608

Review 2.  Carbohydrate binding modules: biochemical properties and novel applications.

Authors:  Oded Shoseyov; Ziv Shani; Ilan Levy
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

3.  A single donor is sufficient to produce a highly functional in vitro antibody library.

Authors:  M Frank Erasmus; Sara D'Angelo; Fortunato Ferrara; Leslie Naranjo; André A Teixeira; Rebecca Buonpane; Shaun M Stewart; Horacio G Nastri; Andrew R M Bradbury
Journal:  Commun Biol       Date:  2021-03-19

4.  Novel Phage Display-Derived Anti-Abrin Antibodies Confer Post-Exposure Protection against Abrin Intoxication.

Authors:  Adva Mechaly; Ron Alcalay; Tal Noy-Porat; Eyal Epstein; Yoav Gal; Ohad Mazor
Journal:  Toxins (Basel)       Date:  2018-02-13       Impact factor: 4.546

5.  Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice.

Authors:  Tal Noy-Porat; Adva Mechaly; Yinon Levy; Efi Makdasi; Ron Alcalay; David Gur; Moshe Aftalion; Reut Falach; Shani Leviatan Ben-Arye; Shirley Lazar; Ayelet Zauberman; Eyal Epstein; Theodor Chitlaru; Shay Weiss; Hagit Achdout; Jonathan D Edgeworth; Raghavendra Kikkeri; Hai Yu; Xi Chen; Shmuel Yitzhaki; Shmuel C Shapira; Vered Padler-Karavani; Ohad Mazor; Ronit Rosenfeld
Journal:  iScience       Date:  2021-04-26

6.  Isolation of Anti-Ricin Protective Antibodies Exhibiting High Affinity from Immunized Non-Human Primates.

Authors:  Tal Noy-Porat; Ronit Rosenfeld; Naomi Ariel; Eyal Epstein; Ron Alcalay; Anat Zvi; Chanoch Kronman; Arie Ordentlich; Ohad Mazor
Journal:  Toxins (Basel)       Date:  2016-03-03       Impact factor: 4.546

7.  A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes.

Authors:  Tal Noy-Porat; Efi Makdasi; Ron Alcalay; Adva Mechaly; Yinon Levy; Adi Bercovich-Kinori; Ayelet Zauberman; Hadas Tamir; Yfat Yahalom-Ronen; Ma'ayan Israeli; Eyal Epstein; Hagit Achdout; Sharon Melamed; Theodor Chitlaru; Shay Weiss; Eldar Peretz; Osnat Rosen; Nir Paran; Shmuel Yitzhaki; Shmuel C Shapira; Tomer Israely; Ohad Mazor; Ronit Rosenfeld
Journal:  Nat Commun       Date:  2020-08-27       Impact factor: 14.919

8.  Clonal array profiling of scFv-displaying phages for high-throughput discovery of affinity-matured antibody mutants.

Authors:  Yuki Kiguchi; Hiroyuki Oyama; Izumi Morita; Mai Morikawa; Asuka Nakano; Wakana Fujihara; Yukari Inoue; Megumi Sasaki; Yuki Saijo; Yuki Kanemoto; Kaho Murayama; Yuki Baba; Atsuko Takeuchi; Norihiro Kobayashi
Journal:  Sci Rep       Date:  2020-08-24       Impact factor: 4.379

Review 9.  Prokaryotic expression of antibodies and affibodies.

Authors:  Luis Angel Fernández
Journal:  Curr Opin Biotechnol       Date:  2004-08       Impact factor: 9.740

Review 10.  The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies.

Authors:  Anna Vaisman-Mentesh; Matias Gutierrez-Gonzalez; Brandon J DeKosky; Yariv Wine
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.